Rockwell Medical – Trademark Portfolio

Entity Type: 03

Rockwell Medical holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ROCKWELL MEDICAL and TRIFERIC FERRIC PYROPHOSPHATE CITRATE. The owner is based in Wixom, MI.

30142 Wixom Road

Wixom, MI 48393

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Rockwell Medical's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Rockwell Medical have?

Rockwell Medical has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.

What trademark classes does Rockwell Medical file in?

Rockwell Medical files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Rockwell Medical's most well-known trademarks?

Rockwell Medical's registered trademark portfolio includes well-known marks such as ROCKWELL MEDICAL and TRIFERIC FERRIC PYROPHOSPHATE CITRATE. These are among 3 currently registered trademarks in the portfolio.

What is Rockwell Medical's trademark registration success rate?

Rockwell Medical has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.